Main View
This view is used for searching all possible sources.
First Page Previous Page 1 2 Next Page Last Page
 
1
Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine.
2009-06-30

This open-label, randomised, controlled study examined antibody persistence following infant vaccination at 2, 3 and 4 months of age with either an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Haemophilus influenzae type b (DT(5)aP-IPV-Hib; Pediacel) or a whole-cell pertussis (DTwP//Hib+oral poliomyelitis vaccine [OPV]) combination vaccine, given ...

PubMed

2
Persistence of antibodies at 5-6 years of age for children who had received a primary series vaccination with a pentavalent whole-cell pertussis vaccine and a first booster with a pentavalent acellular pertussis vaccine: immunogenicity and tolerance of second booster with a tetravalent acellular vaccine at 5-6 years of age.
2004-03-29

The main objective of this study was to assess in 5-6-year-old French children (n=162) the persistence of antibodies induced by a primary series vaccination (at 2-4 months of age) with a pentavalent whole-cell pertussis combined vaccine (DTwcP-IPV-Hib; Pentacoq) and a first booster (at 12-16 months of age) with a pentavalent two-component acellular pertussis combined vaccine ...

PubMed

3
Changes in DT vaccine frequency and indications for use following introduction of DTaP vaccine.
2010-05-06

Our population-based study among HMO members under seven years of age in 1993-2000 showed that frequency of diphtheria and tetanus toxoid vaccine (DT) use declined significantly following the introduction of acellular pertussis-containing (DTaP) vaccine. We also observed changes in indications for DT following the transition to DTaP among children under ...

PubMed

4
Randomized trial on the safety, tolerability, and immunogenicity of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, administered concomitantly with a combined tetanus, reduced diphtheria, and acellular pertussis vaccine in adolescents and young adults.
2010-02-17

This study evaluated the safety, tolerability, and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine, MenACWY-CRM, when administered concomitantly with a combined tetanus, reduced diphtheria, and acellular pertussis (Tdap) vaccine, in subjects aged 11 to 25 years. Subjects received either MenACWY-CRM and Tdap, MenACWY-CRM ...

PubMed

5
Randomized Trial on the Safety, Tolerability, and Immunogenicity of MenACWY-CRM, an Investigational Quadrivalent Meningococcal Glycoconjugate Vaccine, Administered Concomitantly with a Combined Tetanus, Reduced Diphtheria, and Acellular Pertussis Vaccine in Adolescents and Young Adults? �
2010-04-17

This study evaluated the safety, tolerability, and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine, MenACWY-CRM, when administered concomitantly with a combined tetanus, reduced diphtheria, and acellular pertussis (Tdap) vaccine, in subjects aged 11 to 25 years. Subjects received either MenACWY-CRM and Tdap, MenACWY-CRM ...

PubMed Central

6
Reduced-antigen-content-diphtheria-tetanus-acellular-pertussis and inactivated polio vaccine as a booster for adolescents 10 to 14 years of age.
2005-03-22

High rates of pertussis disease in adolescents suggest that additional boosting against pertussis would be beneficial. A combined acellular-pertussis-containing booster vaccine (dTpa-IPV; Boostrixtrade mark Polio, n =440) was compared to separately administered dTpa (Boostrixtrade mark) and inactivated polio virus (IPV; Imovax Polio((R)), n =219), and to DTPa-IPV ...

PubMed

7
A DTaP-IPV//PRP?T vaccine (Pentaxim�): a review of 16 years' clinical experience.
2011-07-12

Owing to their low reactogenicity, confirmed efficacy and availability in combination vaccines, acellular pertussis (aP)-inactivated poliovirus (IPV) combined vaccines are now included in various national immunization programs worldwide. We provide an overview of 16 years of clinical experience with a diphtheria (D), tetanus (T), aP, IPV and Haemophilus influenzae type b (Hib) ...

PubMed

8
Update on immunizations in children and adolescents.
2008-06-01

Over the past few years, there have been many changes to the recommendations for children and adolescents by the Advisory Committee on Immunization Practices. These include dividing the immunization schedule into two parts (i.e., ages birth to six years and seven to 18 years, with catch-up schedules for each group); expanding the recommendations for influenza vaccine to children ages six months to ...

PubMed

9
Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.
2010-02-26

This Phase III study evaluates an investigational quadrivalent meningococcal CRM(197) conjugate vaccine, MenACWY-CRM (Novartis Vaccines), when administered concomitantly or sequentially with two other recommended adolescent vaccines; combined tetanus, reduced diphtheria and acellular pertussis (Tdap), and human papillomavirus (HPV) vaccine. In this ...

PubMed

10
Meningococcal quadrivalent (serogroups A, C, w135, and y) conjugate vaccine (Menveo): in adolescents and adults.
2010-10-01

Menveo is a quadrivalent meningococcal polysaccharide conjugate vaccine containing the four Neisseria meningitidis capsular polysaccharides, A, C, W135, and Y, each conjugated to the mutant diphtheria toxin, known as crossreactive material 197 (CRM(197)). Administration of a single dose of the Menveo vaccine elicited a strong immune response against all four vaccine serogroups ...

PubMed

11
KINRIX� (Diphtheria and Tetanus Toxoids and Acellular Pertussis ...

... Product: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine; KINRIX FDA STN: 125260 ...

Center for Biologics Evaluation and Research (CBER)

12
Vaccination coverage among adolescents aged 13-17 years - United States, 2007.
2008-10-10

Three new vaccines have been recommended for adolescents by the Advisory Committee for Immunization Practices (ACIP) since 2005: meningococcal conjugate vaccine (MCV4; 1 dose), tetanus, diphtheria, acellular pertussis vaccine (Tdap; 1 dose), and quadrivalent human papillomavirus vaccine (HPV4; 3 doses). ACIP also recommends that adolescents should receive ...

PubMed

13
National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2008.
2009-09-18

In recent years, the Advisory Committee on Immunization Practices (ACIP) has recommended three newly licensed vaccines: meningococcal conjugate vaccine (MCV4; 1 dose); tetanus, diphtheria, acellular pertussis vaccine (Tdap; 1 dose); and (for girls) quadrivalent human papillomavirus vaccine (HPV4; 3 doses). ACIP also recommends that adolescents receive ...

PubMed

14
SPECTROPHOTOMETRIC STUDIES ON THE ACETATE COMPLEXES OF QUADRIVALENT PLUTONIUM IN AQUEOUS SOLUTION
1963-01-01

The formation of quadrivalent plutonium complexes was studied in aqueous sodium acetate solutions in relation to pH. The values of the stability constants were determined. The composition and formation characteristics of various complexes were also determined. (TCO)

Energy Citations Database

15
Recombinant Human Papillomavirus (HPV) Quadrivalent Vaccine

This page contains brief information about recombinant human papillomavirus (HPV) quadrivalent vaccine and a collection of links to more information about the use of this vaccine, research results, and ongoing clinical trials.

Cancer.gov

16
Minutes - NASA Occupational Health

Jun 7, 2007 ... Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory ... will speak on the topic of Cervical Cancer and HPV. ...

NASA Website

17
FDA Approval for a Recombinant Human Papillomavirus (HPV) Quadrivalent Vaccine

Information from the FDA about the approval of this drug and the clinical trials that led to the approval.

Cancer.gov

18
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis ...

... US. -. Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed. -. Products. Adacel Sanofi Pasteur, Ltd. ...

Center for Biologics Evaluation and Research (CBER)

19
Pentacel - Diphtheria and Tetanus Toxoids and Acellular Pertussis ...

... Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) Reconstituted with Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined ...

Center for Biologics Evaluation and Research (CBER)

20
Methods of Producing Freeze-Dried Acellular Vascular ...
1998-02-01

... Producing Freeze-Dried Acellular Vascular, Peripheral Nerve and ... ANATOMY), *VASCULAR DISEASES, *ANATOMICAL MODELS, *DURA MATER ...

DTIC Science & Technology

First Page Previous Page 1 2 Next Page Last Page
 
First Page Previous Page 1 2 Next Page Last Page
 
21
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed ...

... Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine. -. Product. Kinrix. -. Contact Us. Consumer Affairs Branch ( ...

Center for Biologics Evaluation and Research (CBER)

22
Deep Anterior Lamellar Keratoplasty (DALK) Using Acellular Corneal Tissue Promotes Corneal Allograft Survival in High Risk Patients
2010-08-02

Glycerin Cryopreserved Acellular Corneal Tissue; Deep Anterior Lamellar Keratoplasty; High Risk Keratoplasty

ClinicalTrials.gov

23
Behavior of the Acellular Slime Mold Physarum Polycephalum

Jul 23, 2011 ... The Gravity Related Behavior of the Acellular Slime Mold Physarum Polycephalum ( SLIME) experiment was flown as part of Biorack, ...

NASA Website

24
What's New from OODP

... with newly diagnosed Philadelphia chromosome positive chronic ... myeloma who have received one prior therapy ... FDA licensed Quadrivalent Human Papillomavirus (Types 6 ...

Center for Drug Evaluation (CDER)

25
Gardasil: JAMA Article: Postlicensure Safety Surveillance, for ...

... Animal & Veterinary; Cosmetics; Radiation-Emitting Products; Tobacco ... Gardasil: JAMA Article: Postlicensure Safety Surveillance, for Quadrivalent ...

Center for Biologics Evaluation and Research (CBER)

26
Computer Generation of Vertex-Graphs.
1973-07-01

... and q quadrivalent vertices, from graphs having (t + 2q) trivalent vertices. This method, however, will generate redundant vertex-graphs and some ...

DTIC Science & Technology

27
Briefing Information for the December 7, 2010 Meeting of the ...

... Animal & Veterinary; Cosmetics; Radiation-Emitting Products; Tobacco ... Gardasil: JAMA Article: Postlicensure Safety Surveillance for Quadrivalent ...

Center for Biologics Evaluation and Research (CBER)

29
Workshop on Acellular Pertussis Vaccines Held at Bethesda, Maryland on September 22-24, 1986, Transcript.
1986-01-01

The document is the printed transcript of a workshop held to discuss the current status of research to develop and clinically test new acellular pertussis vaccines.

National Technical Information Service (NTIS)

30
THE KINETICS OF OXIDATION OF QUADRIVALENT URANIUM IONS BY HYDROGEN PEROXIDE IN PERCHLORIC AND SULPHURIC ACID SOLUTIONS
1963-01-01

The rate constants, activation energies, and frequency factors of uranium quadrivalent ion oxidation by hydrogen in perchloric and sulphuric acid solutions were determined using a spectrophotometric method. Particular attention was paid to the influence of anions on kinetics of the oxidation of Fe/ sup 2+/ ions. The results are discussed. (TCO)

Energy Citations Database

31
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, Vol. 56, RR-2, March 23, 2007.
2007-01-01

These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a quadrivalent human papillomavirus (HPV) vaccine licensed by the U.S. Food and Drug Administration on June 8, 2006. This report s...

National Technical Information Service (NTIS)

32
Method for producing electricity from a fuel cell having solid-oxide ionic electrolyte
1984-01-01

Stabilized quadrivalent cation oxide electrolytes are employed in fuel cells at elevated temperatures with a carbon and/or hydrogen containing fuel anode and an oxygen cathode. The fuel cell is operated at elevated temperatures with conductive metallic coatings as electrodes and desirably having the electrolyte surface blackened. Of particular interest as the ...

Energy Citations Database

33
Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study
2008-12-02

Objective To describe the outcomes of clinical evaluation, skin testing, and vaccine challenge in adolescent schoolgirls with suspected hypersensitivity to the quadrivalent human papillomavirus vaccine introduced in Australian schools in 2007.Design Retrospective cohort study.Setting Two tertiary paediatric allergy centres in Victoria and South Australia, ...

PubMed Central

34
Dibutyl Phosphates of the Quadrivalent Plutonium, Zirconium and Thorium Formed in Tri-N-Butyl Phosphate (TBP) Solutions.
1978-01-01

The conditions for the formation of di-n-butyl phosphates of zirconium, thorium and quadrivalent plutonium which separate out from solutions of di-n-butyl phosphoric acid (DBP, HA) in a mixture of 10 vol% tri-n-butyl phosphate (TBP) with organic diluting ...

National Technical Information Service (NTIS)

35
Autistic Spectrum Disorder and Vaccines

Page 1. Post-Approval Adverse Event Review: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated ...

Center for Biologics Evaluation and Research (CBER)

First Page Previous Page 1 2 Next Page Last Page